Fluvoxamine Impurity 9

Determination of related substances of fluvoxamine maleate extended-​release tablets by HPLC
By Lu, Wenqi; Huang, Tao
From Jinri Yaoxue (2016), 26(12), 844-847
 
A stability indicating HPLC method for the determination of fluvoxamine in pharmaceutical dosage forms
By Souri, Effat; Donyayi, Hassan; Ahmadkhaniha, Reza; Tehrani, Maliheh Barazandeh
From Iranian Journal of Pharmaceutical Research (2015), 14(4), 1059-1065
 
Quantitative assessment of photostability and photostabilization of Fluvoxamine and its design for actinometry
By Maafi, Mounir; Maafi, Wassila
From Photochemical & Photobiological Sciences (2015), 14(5), 982-994

Spectrophotometric methods for the assay of fluvoxamine maleate using chromogenic reagents
By Annapurna, V.; Jyothi, G.; Nagalakshmi, V.; Sailaja, B. B. V.
From Journal of the Indian Chemical Society (2010), 87(11), 1369-1372

Fluvoxamine Impurity 9 is chemically 13-Oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid. Fluvoxamine Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Fluvoxamine Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluvoxamine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.